Comments
Loading...

Cytek Biosciences

CTKBNASDAQ
Logo brought to you by Benzinga Data
$5.66
-0.03-0.53%
At close: -
$5.66
0.000.00%
After Hours: 4:00 PM EDT

Cytek Biosciences (NASDAQ:CTKB) Stock, Earnings Estimates, EPS, And Revenue

Cytek Biosciences reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.

Earnings Date
Feb 26
EPS Estimate
$0.110
Quarterly Revenue Estimate
$60.89M
Annual Revenue
(as of Sep 30)
$201.21M

Analyze the earnings history of Cytek Biosciences using advanced sorting and filters.

Data brought to you by Benzinga APIs

Cytek Biosciences (CTKB) Earnings Per Share

Quarterly Earnings Surprise Amount

Fiscal QuarterDate ReportedActual EPSEstimated EPSSurprise %
Q32024-11-05$0.01$-0.01200.0 %
Q22024-08-06$-0.08$-0.03-166.7 %
Q12024-05-08$-0.05$-0.04-25.0 %
Q42024-02-28$0.04$0100.0 %

Cytek Biosciences (CTKB) Revenue

Quarterly Revenue Surprise Amount

Fiscal QuarterDate ReportedActual RevenueEstimated RevenueSurprise %
Q32024-11-05$51.50M$50.70M1.58 %
Q22024-08-06$46.62M$49.53M-5.88 %
Q12024-05-08$44.86M$43.55M3.01 %
Q42024-02-28$58.23M$56.58M2.92 %

FAQ

Q

When is Cytek Biosciences (NASDAQ:CTKB) reporting earnings?

A

Cytek Biosciences (CTKB) is scheduled to report earnings on February 26, 2025. The last reported earnings were for reported on November 5, 2024 for Q3.

Q

What were the latest earnings per share (EPS) for Cytek Biosciences (NASDAQ:CTKB)?

A

The Actual EPS was $0.01, which beat the estimate of $-0.01.

Q

What were Cytek Biosciences’s (NASDAQ:CTKB) revenues?

A

The Actual Revenue was $51.5M, which beat the estimate of $50.7M.

Browse earnings estimates, EPS, and revenue on all stocks.